secwatch / observer
8-K filed November 9, 2023, 6:59 PM ET ticker ALBT CIK 0001630212
regulatory confidence high sentiment negative materiality 0.60

Avalon GloboCare Corp. (ALBT): Nasdaq/NYSE listing notice — Avalon GloboCare receives Nasdaq bid price deficiency notice; 180-day cure period to May 1, 2024

Avalon GloboCare Corp.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

Avalon GloboCare Corp. received a nasdaq noncompliance notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

Exchange
nasdaq
Notice
noncompliance notice
Deficiency
minimum bid price
Rules
5550(a)(2), 5810(c)(3)(A)
Exact text from the filing
November 3, 2023, Avalon GloboCare Corp. (the “Company”) received written notice (the “Notice”) from the Nasdaq Stock Market, LLC (“Nasdaq”) that the closing bid price for the Company’s common stock had been below $1.00 per share for the previous 30 consecutive business days, and that the Company is therefore not in compliance with the minimum bid price requirement for continued listing on the Nasdaq Capital Market as set forth in Nasdaq Listing Rule 5550(a)(2). The Notice has no immediate effect on the listing or trading of the Company’s common stock on the Nasdaq Capital Market. In accordanc
View on SEC.gov

20 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

Avalon GloboCare Corp. filing history →

Source: SEC EDGAR
accession 0001213900-23-085256
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.